If you are working with lyophilised tirzepatide — a research-grade powdered vial rather than a Zepbound or Mounjaro pre-filled pen — the single most important number you will ever write down is the one on the BAC water bottle. Draw the wrong volume and every dose for the next four weeks is wrong by the same ratio. This article is a reconstitution reference: a vial-size × diluent-volume chart, insulin-syringe unit conversions for every SURMOUNT dose, and the two math mistakes that account for the majority of under- and over-dosing in research settings.
Key Takeaways
- Concentration = mg of peptide ÷ mL of BAC water. Everything downstream — syringe marks, dose accuracy, total doses per vial — follows from this one ratio.
- A U-100 insulin syringe reads in "units," not millilitres. 100 units = 1 mL. 10 units = 0.1 mL. Memorise this before touching a vial.
- Bacteriostatic water (0.9% benzyl alcohol) is the standard diluent. Sterile water for injection is preservative-free and shortens stability.
- 1 mL BAC into a 10 mg vial is the most common reconstitution — it yields 10 mg/mL, so 10 units on a U-100 syringe = 1 mg.
- Reconstituted tirzepatide is generally considered stable for about 28 days refrigerated at 2–8 °C, protected from light.
- Swirl, do not shake. Vigorous agitation can denature the peptide and produce visible cloudiness or foam.
What tirzepatide reconstitution actually means
FDA-approved tirzepatide (Mounjaro and Zepbound) ships pre-reconstituted inside a single-dose pen or vial — the user never mixes anything. Research-grade tirzepatide, by contrast, is shipped as a lyophilised (freeze-dried) powder in a sealed vial. To draw a dose, the user must add a defined volume of sterile diluent, dissolve the peptide, and then withdraw the correct unit volume on an insulin syringe. The dose you deliver depends on three variables working together:
- The amount of peptide in the vial (e.g., 5, 10, 15, 30, or 60 mg)
- The volume of BAC water you add (commonly 1 mL, 2 mL, or 3 mL)
- The number of units you draw on a U-100 insulin syringe
The master reconstitution chart
This chart shows the resulting concentration (mg/mL) and the insulin-syringe units needed per 1 mg of tirzepatide, for every common combination of vial size and BAC water volume. Read it as: pick the row for your vial, pick the column for the BAC water you intend to add, and the cell gives you concentration and units-per-milligram.
| Vial size | + 1 mL BAC water | + 2 mL BAC water | + 3 mL BAC water |
|---|---|---|---|
| 5 mg vial | 5 mg/mL → 20 units per 1 mg | 2.5 mg/mL → 40 units per 1 mg | 1.67 mg/mL → 60 units per 1 mg |
| 10 mg vial | 10 mg/mL → 10 units per 1 mg | 5 mg/mL → 20 units per 1 mg | 3.33 mg/mL → 30 units per 1 mg |
| 15 mg vial | 15 mg/mL → 6.7 units per 1 mg | 7.5 mg/mL → 13.3 units per 1 mg | 5 mg/mL → 20 units per 1 mg |
| 30 mg vial | 30 mg/mL → 3.3 units per 1 mg | 15 mg/mL → 6.7 units per 1 mg | 10 mg/mL → 10 units per 1 mg |
| 60 mg vial | 60 mg/mL → 1.7 units per 1 mg | 30 mg/mL → 3.3 units per 1 mg | 20 mg/mL → 5 units per 1 mg |
Rule of thumb: aim for a concentration where your target dose is at least 10 units on the syringe. Doses below 5 units are difficult to measure accurately on a U-100 insulin syringe.
Units required for every SURMOUNT-protocol dose
The SURMOUNT trials used a fixed four-step titration — 2.5 mg week 1–4, 5 mg week 5–8, 7.5 mg week 9–12, 10 mg week 13–16, then 12.5 mg or 15 mg for maintenance. The chart below translates each of those doses into the insulin-syringe units you would draw at three common dilutions.
| Weekly dose | Units at 10 mg/mL (e.g., 10 mg vial + 1 mL) | Units at 5 mg/mL (e.g., 10 mg vial + 2 mL) | Units at 3.33 mg/mL (e.g., 10 mg vial + 3 mL) |
|---|---|---|---|
| 2.5 mg (start) | 25 units | 50 units | 75 units |
| 5 mg | 50 units | 100 units (full syringe) | 150 units (requires 2 draws) |
| 7.5 mg | 75 units | 150 units (2 draws) | 225 units (not practical) |
| 10 mg | 100 units | 200 units (2 draws) | 300 units (not practical) |
| 12.5 mg | 125 units (2 draws) | 250 units (not practical) | Not practical |
| 15 mg (max) | 150 units (2 draws) | 300 units (not practical) | Not practical |
This is why the dilution choice is strategic. A 10 mg vial reconstituted with 1 mL BAC water works for every SURMOUNT dose up to 10 mg in a single injection. For 12.5 mg or 15 mg, a 15 mg or 30 mg vial at 1 mL dilution gives a cleaner single-draw regimen.
The diluent — why bacteriostatic water and not sterile water
Bacteriostatic water for injection (BAC) contains 0.9% benzyl alcohol as a preservative. It is designed for multi-dose vials where the stopper will be punctured repeatedly over several weeks. Sterile water for injection is preservative-free and intended for single-use dilution; using it for a multi-use research reconstitution reduces the stability window and raises contamination risk.
Choose BAC water for any reconstitution you intend to draw from more than once. Match the volume to the chart above and inject it slowly down the inner wall of the vial, not directly onto the lyophilised pellet.
Mixing technique — swirl, do not shake
After adding BAC water, hold the vial by the cap and roll or swirl it gently between your palms until the powder dissolves. This typically takes 20–60 seconds and produces a clear, colourless solution. Vigorous shaking introduces air, generates foam, and can mechanically denature the peptide. A reconstituted vial that is cloudy, discoloured, or contains visible particulates should be discarded.
Storage and stability
Reconstituted tirzepatide is generally stored at 2–8 °C (standard refrigerator) and protected from light. Published and manufacturer stability data for the branded product supports approximately 28 days of refrigerated use; most research-grade protocols treat 28 days as the practical upper limit. Freezing a reconstituted vial can damage the peptide and is not advised. Lyophilised (unreconstituted) vials are typically stable far longer, which is why most protocols reconstitute one vial at a time.
Common reconstitution errors
Two math errors dominate the "I think my tirzepatide is not working" conversations in research settings.
- Dividing instead of multiplying when counting units. If you reconstitute a 10 mg vial with 2 mL BAC water, you have 5 mg/mL, meaning 1 mg = 20 units on a U-100 syringe. Users sometimes mistakenly read "5 mg/mL" as "5 units = 1 mg" and administer four times too much, or four times too little.
- Confusing a 1 mL insulin syringe with a 3 mL tuberculin syringe. A 1 mL insulin syringe reads 0–100 units; a 3 mL syringe reads in mL and tenths. Reading "0.1 mL" as "10 units" works only on a U-100 insulin syringe. On a tuberculin syringe, the markings are different scales entirely.
A third quieter error: using the wrong diluent and shortening stability unknowingly. Any time a protocol specifies "BAC water," do not substitute sterile saline, sterile water, or anything else without recalculating stability.
Choosing a dilution strategically
The decision of how much BAC water to add is not just a math question — it is a dosing-strategy question for the next several weeks. Three practical heuristics help:
- Fewer units per dose = easier to inject but harder to measure. Highly concentrated reconstitutions make small doses hard to draw accurately. A 2.5 mg SURMOUNT starting dose on a 30 mg + 1 mL dilution (30 mg/mL) is only 8 units — about the lower limit of good insulin-syringe accuracy.
- More units per dose = easier to measure but may exceed syringe capacity. Very dilute reconstitutions give you lots of room for accurate small doses but can push larger doses above the 100-unit mark on a 1 mL syringe, requiring two injections per dose.
- Aim for the sweet spot of 10–60 units per dose. That range balances measurement accuracy against single-draw convenience across typical SURMOUNT titration.
Write the chosen dilution directly onto the vial with a permanent marker the moment you reconstitute. The arithmetic is unforgiving if you remember the wrong number three weeks later.
Needle gauge, site rotation, and injection depth
For subcutaneous tirzepatide injection, a 29–31 gauge, 4–8 mm insulin syringe needle is standard. Common injection sites are the abdomen (at least 5 cm from the navel), the outer thigh, and the back of the upper arm. Rotate sites across weeks to reduce the risk of lipohypertrophy — a soft, slightly raised area of fatty tissue that can form at repeatedly used sites and alter absorption. Pinching a fold of skin and injecting at a 45–90 degree angle keeps delivery in the subcutaneous layer rather than the muscle below.
Conclusion
Reconstitution is a two-equation problem: concentration equals milligrams divided by millilitres, and insulin-syringe units equal 100 times the millilitres you need to draw. Pick a dilution that places your target dose above 10 units and below 100 units (one syringe fill), use bacteriostatic water, swirl gently, refrigerate, and discard at 28 days or earlier if the solution changes appearance.
Research-grade reconstitution is not inherently dangerous when done carefully, but the only safety net is arithmetic. Write your dilution on the vial label the moment you reconstitute, and verify the units-per-milligram against the chart above before every single draw.
Frequently Asked Questions
How much BAC water should I add to a 10 mg tirzepatide vial?
1 mL of bacteriostatic water is the most common and practical choice. This yields a 10 mg/mL solution in which every 10 units on a U-100 insulin syringe equals 1 mg of tirzepatide, so SURMOUNT doses from 2.5 mg to 10 mg are easy single-draw volumes.
Can I use sterile water instead of bacteriostatic water?
You can mix with sterile water, but stability drops substantially because there is no preservative. For a multi-dose, multi-week research reconstitution, bacteriostatic water (0.9% benzyl alcohol) is the standard choice.
How long is reconstituted tirzepatide good for in the fridge?
Reconstituted tirzepatide is generally considered stable for approximately 28 days refrigerated at 2–8 °C and protected from light. Discard sooner if the solution becomes cloudy, discoloured, or contains particulates.
What size insulin syringe do I need?
A standard U-100 insulin syringe is used — 29G to 31G, 0.5 mL or 1 mL capacity, with 100-unit markings. A 0.5 mL syringe is easier to read for small doses; a 1 mL syringe is useful when a dose requires more than 50 units.
Why does my syringe need two draws for one injection?
Because your dilution has placed your dose above 100 units (above 1 mL), which exceeds one insulin syringe. The fix is to reconstitute at a higher concentration — use less BAC water next time so the same dose becomes a single-draw volume.
Does swirling instead of shaking really matter?
Yes. Peptides are physically sensitive to shear forces introduced by shaking. Vigorous shaking can denature the molecule, generate foam, and reduce potency even when the solution still looks clear. Slow swirling preserves the structure.
Sources
- FDA Zepbound (tirzepatide) prescribing information. 2023. accessdata.fda.gov Zepbound label
- Jastreboff AM et al. SURMOUNT-1. NEJM. 2022. nejm.org/doi/full/10.1056/NEJMoa2206038
- ClinicalTrials.gov. SURMOUNT-1 (NCT04184622). clinicaltrials.gov/study/NCT04184622
- FDA. Human drug compounding. fda.gov/drugs/human-drug-compounding
- PubMed. Tirzepatide pharmacology literature. pubmed.ncbi.nlm.nih.gov/?term=tirzepatide
Research disclaimer: This article is written by the Peptides Hive Research Desk and is a reference for lyophilised research-grade peptide handling. It is educational, not medical, advice. FDA-approved tirzepatide (Mounjaro, Zepbound) is pre-reconstituted and does not require user mixing. Any clinical use of tirzepatide should be directed by a licensed prescriber using approved product.
